Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
Study NCT ID:
NCT04513951
Status:
COMPLETED
Last Update Posted:
2025-01-09
First Post:
2020-08-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients
Sponsor:
Gruppo Oncologico del Nord-Ovest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-12
First Submit QC Date:
None
Study First Post Date:
2020-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-08
Last Update Post Date:
2025-01-09
Last Update Post Date Type:
ACTUAL